Argenx announces approval of vyvgart (efgartigimod alfa) in japan for adults with primary immune thrombocytopenia

Vyvgart ® now approved in japan for both generalized myasthenia gravis and primary immune thrombocytopenia (itp)
ARGX Ratings Summary
ARGX Quant Ranking